My wife (JeanBean on this forum) qualified for a genomic test to determine whether she should have chemo. She was Stage 2a, node negative, oestrogen receptor positive, HER2 negative. Our oncologist supported her getting a genomic test. The one they use at the SAN, Wahroonga NSW is EndoPredict - because its a bit cheaper than Oncotype DX and doesn't take as long. For Oncotype DX they have to send samples off to the USA for testing. Anyway, it cost us $2990 (non refundable by anyone) and the result was just over the threshold into the high risk range so JeanBean had to go through chemo anyway. Since then there has been a trial using Oncotype DX which shows that many women who were in the grey risk area before can now be classified as low risk and don't need chemo. So if we were doing this all again (heaven forbid) we would insist on Oncotype DX.